You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A randomised placebo-controlled double-blind Phase I study to assess the safety tolerability pharmacokinetics and pharmacodynamics of single and multiple oral doses of AZD1981 in healthy male subjects
- Disease
- chronic obstructive pulmonary disease, asthma
- Drug Name
- AZD1981
- Generic Name
- AZD1981
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jun 1, 2009
- Study Name
- D9831C00003
- Study Id
- D9831C00003
- ClinicalTrials.gov ID
- NCT00918398
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
